Hydrogenophaga defluvii sp nov and Hydrogenophaga atypica sp nov., isolated from activated sludge

Two Gram-negative, oxidase-positive rods (strains BSB 9.5T and BSB 41.8T) isolated from wastewater were studied using a polyphasic approach. 16S rRNA gene sequence comparisons demonstrated that both strains cluster phylogenetically within the family Comamonadaceae: the two strains shared 99·9 % 16S rRNA gene sequence similarity and were most closely related to the type strains of Hydrogenophaga palleronii (98·5 %) and Hydrogenophaga taeniospiralis (98·0 %). The fatty acid patterns and substrate-utilization profiles displayed similarity to the those of the five Hydrogenophaga species with validly published names, although clear differentiating characteristics were also observed. The two strains showed DNA–DNA hybridization values of 51 % with respect to each other. No close similarities to any other Hydrogenophaga species were detected in hybridization experiments with the genomic DNAs. On the basis of these results, two novel Hydrogenophaga species, Hydrogenophaga defluvii sp. nov. and Hydrogenophaga atypica sp. nov. are proposed, with BSB 9.5T (=DSM 15341T=CIP 108119T) and BSB 41.8T (=DSM 15342T=CIP 108118T) as the respective type strains

Histological and biochemical criteria for objective and early selection of grapevine cultivars resistant to Plasmopara viticola

Grapevine breeding is the most effective way to create cultivars resistant to downy mildew (Plasmopara viticola), and to reduce the number of fungicide applications. Four criteria, including histological and biochemical analyses, based on the level of different mechanisms of resistance to grapevine downy mildew, were tested on 42 different cultivars. Plantlets were artificially inoculated with downy mildew and the sporangia density was measured spectrophotometrically 6 d after infection. Callose synthesis in stomata and δ- and ε-viniferin levels at the site of infection were recorded 48 h after inoculation. These observations have allowed the 42 cultivars to be divided into 5 groups: very resistant (VR), resistant (R), less susceptible (LS), susceptible (S) and highly susceptible (HS). All 4 criteria have to be applied to assign the resistance level closer to field conditions. This method allows to rapidly evaluate the level of resistance of seedlings to downy mildew thereby leading to a reduction in duration  of the breeding program by several years.

Effect of Pelleting Temperature on the Activity of Different Enzymes

The effects of different pelleting temperatures on the activity of cellulase, bacterial amylase, fungal amylase, and pentosanase were tested. Samples of a commercial barley-wheat-soybean diet containing different enzyme preparations were pelleted at 60, 70, 80, 90, and 100 C (pellet temperature measured at the die outlet) through a die containing holes 2.5 mm in diameter. Enzymatic analyses were conducted on either soluble substrates or by measuring the ability of the tested enzymes to decrease the viscosity of the diet. Measurements made on soluble substrates suggest that cellulase, fungal amylase, and pentosanase maintained activity when being pelleted at temperatures up to 80 C and bacterial amylase maintained activity at temperatures up to 90 C. Pentosanase and amylases showed little or no effect on the viscosity of the diet. Cellulase addition decreased the viscosity at all temperature levels, even after being pelleted at 90 and 100 C (P < 0.05). No cellulolytic activity was detected on the soluble substrate after these pelleting temperatures. Measurements on a soluble substrate might therefore not always reflect the true stability of a preparation because the ability of a carbohydrase to decrease the viscosity of the digesta is important to its effect in the gastrointestinal tract. Measurements on soluble substrates suggest that cellulase, fungal amylase, and pentosanase can be pelleted at temperatures up to at least 80 C and bacterial amylase up to 90 C without a considerable loss in analyzed activit

Micro RNA Expression after Ingestion of Fucoidan; A Clinical Study

Fucoidans are a class of fucose‐rich sulfated polysaccharides derived from brownmacroalgae that exert a range of biological activities in vitro and in vivo. To generate an unbiasedassessment of pathways and processes affected by fucoidan, a placebo‐controlled double‐blind pilotstudy was performed in healthy volunteers. Blood samples were taken immediately before and 24h after ingestion of a single dose of 1 g of Undaria pinnatifida fucoidan (UPF) or placebo. Levels ofisolated miRNAs were analyzed using Taqman Open Array Human MicroRNA panels. Out of 754miRNAs screened, UPF affected a total of 53 miRNAs. Pathway analysis using the TALOS dataanalysis tool predicted 29 different pathways and processes that were largely grouped into cellsurface receptor signaling, cancer‐related pathways, the majority of which were previouslyassociated with fucoidans. However, this analysis also identified nine pathways and processes thathave not been associated with fucoidans before. Overall, this study illustrates that even a single doseof fucoidans has the potential to affect the expression of genes related to fundamental cellularprocesses. Moreover, it confirms previous data that fucoidans influence immunity, cancer cells,inflammation, and neurological function

Skylab S-193 Radscat microwave measurements of sea surface winds

The S-193 Radscat made extensive measurements of many sea conditions. Measurements were taken in a tropical hurricane (Ava), a tropical storm (Christine), and in portions of extratropical cyclones. Approximately 200 scans of ocean data at 105 kilometer spacings were taken during the first two Skylab missions and another 200 during the final mission when the characteristics of the measurements changed due to damage of the antenna. Backscatter with four transmit/receive polarization combinations and emissions with horizontal and vertical receive polarizations were measured. Other surface parameters investigated for correlation with the measurements included sea temperature, air/sea temperature difference, and gravity-wave spectrum. Methods were developed to correct the microwave measurements for atmospheric effects. The radiometric data were corrected accurately for clear sky and light cloud conditions only. The radiometer measurements were used to recover the surface scattering characteristics for all atmospheric conditions excluding rain. The radiometer measurements also detected the presence of rain which signaled when the scattering measurement should not be used for surface wind estimation. Regression analysis was used to determine empirically the relation between surface parameters and the microwave measurements, after correction for atmospheric effects. Results indicate a relationship approaching square-law at 50 deg between differential scattering coefficient and wind speed with horizontally polarized scattering data showing slightly more sensitivity to wind speed than vertically polarized data

Delivering the power of nanomedicine to patients today

The situation of the COVID-19 pandemic reminds us that we permanently need high-value flexible solutions to urgent clinical needs including simplified diagnostic technologies suitable for use in the field and for delivering targeted therapeutics. From our perspective nanotechnology is revealed as a vital resource for this, as a generic platform of technical solutions to tackle complex medical challenges. It is towards this perspective and focusing on nanomedicine that we take issue with Prof Park's recent editorial published in the Journal of Controlled Release. Prof. Park argued that in the last 15 years nanomedicine failed to deliver the promised innovative clinical solutions to the patients (Park, K. The beginning of the end of the nanomedicine hype. Journal of Controlled Release, 2019; 305, 221\u2013222 [1]. We, the ETPN (European Technology Platform on Nanomedicine) [2], respectfully disagree. In fact, the more than 50 formulations currently in the market, and the recent approval of 3 key nanomedicine products (e. g. Onpattro, Hensify and Vyxeos), have demonstrated that the nanomedicine field is concretely able to design products that overcome critical barriers in conventional medicine in a unique manner, but also to deliver within the cells new drug-free therapeutic effects by using pure physical modes of action, and therefore make a difference in patients lives. Furthermore, the &gt;400 nanomedicine formulations currently in clinical trials are expecting to bring novel clinical solutions (e.g. platforms for nucleic acid delivery), alone or in combination with other key enabling technologies to the market, including biotechnologies, microfluidics, advanced materials, biomaterials, smart systems, photonics, robotics, textiles, Big Data and ICT (information &amp; communication technologies) more generally. However, we agree with Prof. Park that \u201c it is time to examine the sources of difficulty in clinical translation of nanomedicine and move forward \u201c. But for reaching this goal, the investments to support clinical translation of promising nanomedicine formulations should increase, not decrease. As recently encouraged by EMA in its roadmap to 2025, we should create more unity through a common knowledge hub linking academia, industry, healthcare providers and hopefully policy makers to reduce the current fragmentation of the standardization and regulatory body landscape. We should also promote a strategy of cross-technology innovation, support nanomedicine development as a high value and low-cost solution to answer unmet medical needs and help the most promising innovative projects of the field to get better and faster to the clinic. This global vision is the one that the ETPN chose to encourage for the last fifteen years. All actions should be taken with a clear clinical view in mind, \u201c without any fanfare\u201d, to focus \u201con what matters in real life\u201d, which is the patient and his/her quality of life. This ETPN overview of achievements in nanomedicine serves to reinforce our drive towards further expanding and growing the maturity of nanomedicine for global healthcare, accelerating the pace of transformation of its great potential into tangible medical breakthroughs

Quantum protocols for anonymous voting and surveying

We describe quantum protocols for voting and surveying. A key feature of our schemes is the use of entangled states to ensure that the votes are anonymous and to allow the votes to be tallied. The entanglement is distributed over separated sites; the physical inaccessibility of any one site is sufficient to guarantee the anonymity of the votes. The security of these protocols with respect to various kinds of attack is discussed. We also discuss classical schemes and show that our quantum voting protocol represents a N-fold reduction in computational complexity, where N is the number of voters.Comment: 8 pages. V2 includes the modifications made for the published versio

On Multifractal Structure in Non-Representational Art

Multifractal analysis techniques are applied to patterns in several abstract expressionist artworks, paintined by various artists. The analysis is carried out on two distinct types of structures: the physical patterns formed by a specific color (``blobs''), as well as patterns formed by the luminance gradient between adjacent colors (``edges''). It is found that the analysis method applied to ``blobs'' cannot distinguish between artists of the same movement, yielding a multifractal spectrum of dimensions between about 1.5-1.8. The method can distinguish between different types of images, however, as demonstrated by studying a radically different type of art. The data suggests that the ``edge'' method can distinguish between artists in the same movement, and is proposed to represent a toy model of visual discrimination. A ``fractal reconstruction'' analysis technique is also applied to the images, in order to determine whether or not a specific signature can be extracted which might serve as a type of fingerprint for the movement. However, these results are vague and no direct conclusions may be drawn.Comment: 53 pp LaTeX, 10 figures (ps/eps